恶性肿瘤最佳治疗决策的实证调查与伦理探讨

发布时间：2018-03-25 07:12

本文选题：恶性肿瘤　切入点：治疗决策　出处：《医学与哲学(B)》2017年03期

【摘要】：中国的恶性肿瘤治疗决策中往往会有家属的参与,对家属参与决策的道德辩护常常诉诸于后果论,假设家属的参与有利于实现患者的最佳利益,然而这一假设是否成立?笔者通过对北京市两所三甲医院的11组患者、家属和医生进行访谈,分别了解三方参与决策的方式、程度及考虑因素等。本文在三方观点对比分析基础上,结合最佳利益的伦理概念探讨恶性肿瘤的最佳治疗决策。结论是提高患者的自主性有利于形成最佳治疗方案,并实现其最佳利益,医生和家属应该鼓励患者积极参与决策。
[Abstract]:In China, there is often the participation of family members in the decision-making of malignant tumor. The moral defense of family participation in decision-making often appeals to the theory of consequences, assuming that the participation of family members is conducive to the realization of the best interests of patients. However, is this hypothesis true? Through interviews with 11 groups of patients, family members and doctors in two third Class A hospitals in Beijing, the author understands the way, degree and considerations of the three parties' participation in decision-making, respectively. Based on the comparative analysis of the views of the three parties, this paper makes a comparative analysis of the three groups of patients, family members and doctors. Combined with the ethical concept of best interests, this paper discusses the best treatment decision for malignant tumors. The conclusion is that increasing the autonomy of patients is conducive to forming the best treatment scheme and realizing its best interests. Doctors and family members should encourage patients to participate actively in the decision-making.
【作者单位】：北京大学医学人文研究院;解放军305医院;
【基金】：2012年国家社会科学基金项目(13BSH069)
【分类号】：R730.5

【相似文献】